rituximab
Showing 2326 - 2350 of 2,665
Leukemia, Lymphoma Trial in New York (filgrastim, rituximab, cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- filgrastim
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 24, 2013
Follicular Lymphoma Trial in Saint Louis (Combination of treatment modalities)
Completed
- Follicular Lymphoma
- Combination of treatment modalities
-
Saint Louis, MissouriSaint Louis University Cancer Center
May 9, 2014
Non-Hodgkin's Lymphoma, Lymphoma, Large Cell, Diffuse, Mantle Cell Lymphoma, Lymphoma Trial in Japan, Korea, Republic of (SyB
Completed
- Non-Hodgkin's Lymphoma
- +4 more
- SyB L-0501
- Rituximab
-
Nagoya, Aichi, Japan
- +24 more
May 29, 2013
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +2 more
- tanespimycin
- rituximab
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
Burkitt Lymphoma, Non-Hodgkins Lymphoma, Atypical Burkitt Lymphoma Trial in Boston (Rituximab, Cyclophosphamide, Doxorubicin)
Terminated
- Burkitt Lymphoma
- +2 more
- Rituximab
- +9 more
-
Boston, Massachusetts
- +1 more
Apr 17, 2013
Thrombotic Thrombocytopenic Purpura Trial in United States (Rituximab, Plasma exchange, Corticosteroids)
Terminated
- Thrombotic Thrombocytopenic Purpura
- Rituximab
- +2 more
-
Birmingham, Alabama
- +22 more
Jul 18, 2013
Lymphoma Trial in Houston (Etoposide, G-CSF, GM-CSF)
Breast Cancer Trial in Beijing (Wire-localized abnormal node)
Completed
- Breast Cancer
- Wire-localized abnormal node
-
Beijing, ChinaBreast cancer, Peking University Cancer Hospital & Institute
Jun 16, 2014
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus (bendamustine HCl, obatoclax
Withdrawn
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +6 more
- bendamustine hydrochloride
- +2 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jun 5, 2013
Metastatic Melanoma Trial in Vienna (rituximab)
Terminated
- Metastatic Melanoma
- rituximab
-
Vienna, AustriaGeneral Hospital Vienna, Dep. of Dermatology, Division of Immuno
Apr 24, 2013
Myeloma, Lymphoma Trial in Atlanta (Plerixafor)
Completed
- Myeloma
- Lymphoma
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Sep 16, 2014
Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome Trial in Washington DC (D-Galactose)
Completed
- Focal Segmental Glomerulosclerosis
- Steroid Resistant Nephrotic Syndrome
-
Washington DC, District of ColumbiaChildren's National Medical Center
Sep 8, 2014
Non Hodgkin's Follicular Lymphoma Trial in Modena (Bortezomib (VELCADE), Rituximab)
Completed
- Non Hodgkin's Follicular Lymphoma
- Bortezomib (VELCADE)
- Rituximab
-
Modena, ItalyGruppo Italiano Studio Linfomi
Apr 11, 2013
Indolent Non Hodgkin Lymphoma Trial in Modena (Lenalidomide, Rituximab)
Unknown status
- Indolent Non Hodgkin Lymphoma
- Lenalidomide
- Rituximab
-
Modena, MO, ItalyCentro Oncologico Modenese
Apr 9, 2013
Bullous Pemphigoid Trial in Durham (Rituximab)
Completed
- Bullous Pemphigoid
- Rituximab
-
Durham, North CarolinaDuke University Medical Center
Apr 9, 2013
Squamous Cell Carcinoma Trial in Chicago (Cetuximab and Lenalidomide)
Completed
- Squamous Cell Carcinoma
- Cetuximab and Lenalidomide
-
Chicago, IllinoisThe University of Chicago
Nov 17, 2014
Chronic Lymphocytic Leukemia Trial run by the NCI (biological, drug, other)
Completed
- Chronic Lymphocytic Leukemia
- Rituximab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 19, 2013
Chronic Focal Encephalitis, Rasmussen's Encephalitis Trial in San Francisco (Rituximab)
Completed
- Chronic Focal Encephalitis
- Rasmussen's Encephalitis
- Rituximab
-
San Francisco, CaliforniaCalifornia Pacific Medical Center
Mar 20, 2013
Immune Thrombocytopenic Purpura Trial in Monterrey (Rituximab and dexamethasone)
Completed
- Immune Thrombocytopenic Purpura
- Rituximab and dexamethasone
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. Jose E Gonzalez UANL
Mar 21, 2013
Lymphoma Trial in Puerto Rico, South Africa, United States (rituximab)
Completed
- Lymphoma
- rituximab
-
Scottsdale, Arizona
- +68 more
Aug 14, 2013
Malignant Melanoma of Skin Stage III, Metastatic Melanoma Trial in Encinitas (Rituxan)
Unknown status
- Malignant Melanoma of Skin Stage III
- Metastatic Melanoma
-
Encinitas, CaliforniaCalifornia Cancer Associates For Research,cCARE
May 16, 2014
Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in New York (beta-glucan, rituximab)
Terminated
- Leukemia
- +2 more
- beta-glucan
- rituximab
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Mar 18, 2013
Lymphoma, Leukemia Trial in Houston (Zevalin Radioimmunotherapy, Rituximab, Fludarabine)
Completed
- Lymphoma
- Leukemia
- Zevalin Radioimmunotherapy
- +4 more
-
Houston, TexasMD Anderson Cancer Center
Jun 11, 2013